Comparison of the cardiovascular actions of NSC-109,724 (ifosfamide) and cyclophosphamide.
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D001285:Atropine / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D001919:Bradycardia / Q000139:chemically induced; D002319:Cardiovascular System / Q000187:drug effects*; D002744:Chlorpheniramine / Q000494:pharmacology; D003497:Cyclic N-Oxides / Q000008:administration & dosage / Q000494:pharmacology*; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000494:pharmacology*; D004155:Diphenhydramine / Q000494:pharmacology; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004569:Electroencephalography; D005021:Ethylamines / Q000494:pharmacology; D000882:Haplorhini; D006339:Heart Rate / Q000187:drug effects; D006632:Histamine / Q000097:blood / Q000494:pharmacology; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D066298:In Vitro Techniques; D010078:Oxazines / Q000008:administration & dosage / Q000494:pharmacology*; D010477:Perfusion; D013997:Time Factors; D014309:Tripelennamine / Q000494:pharmacology
D000970:Antineoplastic Agents; D003497:Cyclic N-Oxides; D005021:Ethylamines; D006634:Histamine H1 Antagonists; D010078:Oxazines; D014309:Tripelennamine; D002744:Chlorpheniramine; D001285:Atropine; D006632:Histamine; D004155:Diphenhydramine; D003520:Cyclophosphamide